CVS HEALTH CORPORATION Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation
CVS HEALTH CORPORATION (CVS) had Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation of $171.00 million as of 2025-12-31, per its 10-K filed 2026-02-10.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Tax Deferred Expense
us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation · last filed 2026-02-10
- 2025-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation $171.00M.
- 2024-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation $168.00M.
- 2023-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation $168.00M.
- 2022-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation $153.00M.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation |
|---|---|
| 2025-12-31 | $171.00M 10-K · filed 2026-02-10 |
| 2024-12-31 | $168.00M 10-K · filed 2026-02-10 |
| 2023-12-31 | $168.00M 10-K · filed 2025-02-12 |
| 2022-12-31 | $153.00M 10-K · filed 2024-02-07 |
| 2021-12-31 | $193.00M 8-K · filed 2023-05-25 |
| 2020-12-31 | $238.00M 10-K · filed 2022-02-09 |
| 2019-12-31 | $191.00M 10-K · filed 2021-02-16 |
| 2018-12-31 | $243.00M 10-K · filed 2020-02-18 |
| 2017-12-31 | $246.00M 8-K · filed 2019-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PETMED EXPRESS INC (PETS) | United States | $0.034B | -1.41 |